NDC 60977-141-27 - Protopam Chloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 60977-141
Requested NDC: 60977-141-27
Package NDCs from labels: 60977-141-27, 60977-141-01
Manufacturer: Baxter Healthcare Corporation
Effective date: 2026-04-01
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Protopam Chloride - Baxter Healthcare Corporation	Baxter Healthcare Corporation	2026-04-01	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2012-07-24	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
60977-141-01	Protopam Chloride	6 in 1 PACKAGE	INJECTION, POWDER, LYOPHILIZED,	6		15
60977-141-27	Protopam Chloride	20 mL in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, LYOPHILIZED,	20		15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60977-141	PROTOPAM CHLORIDE (PRALIDOXIME CHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	14	Current NDC, Legacy NDC, 2 package rows	20250228_2741d8fd-51c2-46be-880b-99f2b20a6137.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60977-141-01	EA - Each	60977-141	d5af37da-bdf1-425c-9bff-87ca8be75b31	1	2012-07-24
60977-141-27	EA - Each	60977-141	a9c49cb0-136b-46b5-8273-25400b4dd281	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PRALIDOXIME CHLORIDE	ACTIVE INGREDIENT	38X7XS076H	PROTOPAM CHLORIDE (PRALIDOXIME CHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	5
PRALIDOXIME	ACTIVE MOIETY	P7MU9UTP52	PROTOPAM CHLORIDE (PRALIDOXIME CHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	5
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	PROTOPAM CHLORIDE (PRALIDOXIME CHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	5

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Protopam Chloride	PRALIDOXIME CHLORIDE	Baxter Healthcare Corporation	2741d8fd-51c2-46be-880b-99f2b20a6137	2026-04-01	Warnings, Adverse reactions	Exact identifier application number: NDA014134 ndc (package): 60977-141-01 ndc (package): 60977-141-27 ndc (product): 60977-141 ndc11 (package): 60977014127 rxcui: 208969 rxcui: 312576 spl id: ce0e8c50-0a21-4dbe-bdc6-e64a26a120c7 spl set id: 2741d8fd-51c2-46be-880b-99f2b20a6137 unii: 38X7XS076H

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.